Last reviewed · How we verify
NCT02125981
The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy
Phase 3 trial testing Limaprost in Cervical Myelopathy in 160 participants. Completed in 1 April 2023.
1 October 2022
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 1 September 2014 |
| Primary completion | 1 October 2022 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Limaprost (LIMAPROST) — full drug profile →
- Placebo
Conditions studied
- Cervical Myelopathy — all drugs for Cervical Myelopathy →
Sponsor
Seoul National University Hospital
Who can join
20 and older, any sex, with Cervical Myelopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The limaprost alfadex can improve the surgical outcomes in patients with cervical myelopathy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence.
Levett JJ, Georgiopoulos M, Martel S, Mugheiry WA, et al · · 2024 · cited 7× · PMID 38955515 · DOI 10.14245/ns.2448140.070
Verify or expand the search:
- PubMed search for NCT02125981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Myelopathy
Currently open trials in the same condition.
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06701422 — Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery · NA · recruiting
- NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
- NCT06486038 — Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement · NA · recruiting
- NCT05183971 — Proprioceptive Deficits in Degenerative Cervical Myelopathy · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02125981 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02125981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing